Alcon - ALC Stock Forecast, Price & News

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ALC shares.
View ALC analyst ratings or view top-rated stocks.

10 Wall Street analysts have issued 12 month target prices for Alcon's stock. Their ALC share price forecasts range from $68.80 to $92.00. On average, they expect the company's stock price to reach $80.63 in the next year. This suggests a possible upside of 7.8% from the stock's current price.
View analysts price targets for ALC or view top-rated stocks among Wall Street analysts.

Alcon's stock was trading at $68.55 at the beginning of the year. Since then, ALC stock has increased by 9.1% and is now trading at $74.80.
View the best growth stocks for 2023 here.

Alcon saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 5,770,000 shares, an increase of 6.7% from the December 31st total of 5,410,000 shares. Based on an average trading volume of 933,700 shares, the short-interest ratio is presently 6.2 days. Currently, 1.2% of the shares of the company are short sold.
View Alcon's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our ALC earnings forecast.

Alcon Inc. (NYSE:ALC) announced its quarterly earnings data on Tuesday, November, 15th. The healthcare company reported $0.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The healthcare company earned $2.12 billion during the quarter, compared to analyst estimates of $2.14 billion. Alcon had a trailing twelve-month return on equity of 6.03% and a net margin of 6.57%.

Alcon announced a dividend on Saturday, April 23rd. Shareholders of record on Monday, May 2nd will be given a dividend of $0.13 per share on Tuesday, May 3rd. This represents a yield of 0.18%. The ex-dividend date is Friday, April 29th.
Read our dividend analysis for ALC.

Alcon issued an update on its FY 2022 earnings guidance on Thursday, December, 15th. The company provided EPS guidance of $2.20-$2.25 for the period, compared to the consensus EPS estimate of $2.28. The company issued revenue guidance of $8.50 billion-$8.70 billion, compared to the consensus revenue estimate of $8.72 billion.

6 employees have rated Alcon Chief Executive Officer Greg D. Wight on Glassdoor.com. Greg D. Wight has an approval rating of 100% among the company's employees. This puts Greg D. Wight in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcon investors own include AT&T (T), Novartis (NVS), Verizon Communications (VZ), International Business Machines (IBM), Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Exxon Mobil (XOM) and AbbVie (ABBV).

Alcon trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALC."

Alcon's stock is owned by many different institutional and retail investors. Top institutional investors include AKO Capital LLP (1.15%), Allspring Global Investments Holdings LLC (0.93%), Manning & Napier Group LLC (0.24%), Assenagon Asset Management S.A. (0.11%), Natixis Advisors L.P. (0.10%) and Mcdaniel Terry & Co. (0.05%).

Shares of ALC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALC stock can currently be purchased for approximately $74.80.

Alcon (NYSE:ALC) has a market capitalization of $36.66 billion and generates $8.29 billion in revenue each year. The healthcare company earns $376 million in net income (profit) each year or $1.15 on an earnings per share basis.

The company employs 24,389 workers across the globe.

Alcon's mailing address is Rue Louis-d`Affry 6, Fribourg V8, 1701. The official website for the company is www.alcon.com. The healthcare company can be reached via phone at 41-58-911-2000, via email at investor.relations@alcon.com, or via fax at 41-58-911-3222.